DNMT1 and esophageal squamous cell carcinoma: The present study suggests that DNMT inhibitors are able to inhibit EMT and improve chemotherapy sensitivity, and the combination of DNMT inhibitors with chemotherapy may reduce tumor volume and improve prognosis for advanced ESCC with chemotherapy resistance.